Skip to content
  • Home
  • Visit our other Journals
    • VJHemOnc
    • VJOncology
    • VJNeurology
    • VJDementia
    • VJHemOnc-E
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJRegenMed
Logo
  • Specialties
    Hematology
    Oncology
    Musculoskeletal Disorder
    Rare Disease
    Metabolic Disorder
    Cardiovascular Disease
    Ophthalmology
    Neurology
    Infectious Disease
    View all Specialties
  • Technologies
    Cell Therapy
    MSC
    iPSC
    Gene Therapy
    Genome Editing
    Extracellular Vesicles
    CAR-T Therapy
    TCR Therapy
    Tissue-Engineering & Biomaterials
    View all Technologies
  • Topics
    Treatment
    Immuno-Oncology
    Trial Updates
    Perspectives
    Manufacturing
    COVID-19
    View all Topics
  • Conferences
    ASH 2022
    TCT 2022
    Meeting on the Med 2022
    ICLE 2022
    Advanced Therapies Week 2022
    TERMIS 2021
    ESGCT 2021
    Meeting on the Mesa 2021
    Advanced Therapies 2021
    View all Conferences
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

collaboration

The importance of collaboration in cell and gene therapy development 2:27
The importance of collaboration in cell and gene therapy development
Delara Motlagh • 27 Jan 2022
Overcoming issues associated with autologous therapies 1:44
Overcoming issues associated with autologous therapies
Cate Dyer • 27 Jan 2022
Innovations in viral vector development 3:34
Innovations in viral vector development
Nathalie Clement • 27 Jan 2022
Increasing patient recruitment to rare disease trials 1:06
Increasing patient recruitment to rare disease trials
Will Chou • 26 Jan 2022
Building collaborative relationships to overcome challenges in the CGT industry 2:46
Building collaborative relationships to overcome challenges in the CGT industry
Sharon Brownlow • 26 Jan 2022
Addressing issues in conducting clinical trials for rare diseases 1:10
Addressing issues in conducting clinical trials for rare diseases
Will Chou • 27 Jan 2022
Regulatory challenges in automating CGT manufacturing 1:04
Regulatory challenges in automating CGT manufacturing
Delara Motlagh • 27 Jan 2022
Cooperation between the American Society of Transplantation and TERMIS 3:00
Cooperation between the American Society of Transplantation and TERMIS
Giuseppe Orlando • 11 Nov 2021
Addressing the regulatory barriers advanced therapies face 1:19
Addressing the regulatory barriers advanced therapies face
Christian Schneider • 29 Oct 2021
Collaboration in the cell & gene therapy industry 1:49
Collaboration in the cell & gene therapy industry
Neil Hunter • 6 Oct 2021
What can the advanced therapies industry learn from the COVID-19 pandemic? 1:44
What can the advanced therapies industry learn from the COVID-19 pandemic?
Matthew Durdy • 6 Oct 2021
International collaboration in advanced therapies 2:56
International collaboration in advanced therapies
Amy DuRoss • 8 Apr 2021
The lasting impact of COVID-19 on the CGT sector 3:10
The lasting impact of COVID-19 on the CGT sector
Stephen Ward • 14 Apr 2021
Journal Pages
  • Specialties
  • Technologies
  • Topics
  • Conferences
Newsletter

Receive the latest news and videos from VJRegenMed via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJRegenMed logo
The content of VJRegenMed is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy